Brief: Teva And Alvotech Announce Selarsdi™ Injection Now Available In The U.S.
21/02/2025 11:07
Feb 21 (Reuters) - Alvotech SA ALVO.O :
* TEVA AND ALVOTECH ANNOUNCE SELARSDI™ (USTEKINUMAB-AEKN)
INJECTION NOW AVAILABLE IN THE U.S.
Source text: ID:nGNX70th7k
Further company coverage: ALVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alvotech SA
See all newsBrief: CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program
Brief: Alvotech and Teva Secure U.S. Settlement Date For AVT06
India's Dr Reddy's rises after EU marketing authorisation for osteoporosis biosimilar
Brief: UK High Court Rules In Favor Of Alvotech Paving Way For AVT06, Biosimilar To Eylea
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm